Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease

American Journal of Nephrology

Volumn 32, Issue 3, 2010, Pages 242-248

  Zinellu, Angelo ^a,b   Loriga, Giacomina ^a   Scanu, Bastianina ^a,c   Pisanu, Elisabetta ^a,c   Sanna, Manuela ^a   Deiana, Luca ^a   Satta, Andrea Ercole ^a   Carru, Ciriaco ^a,c  

^a UNIVERSITY OF SASSARI   (Italy)

^b Porto Conte Ricerche Srl   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Chronic kidney disease; Homocysteine; Homocysteinylation; Low density lipoprotein; Low density lipoprotein S homocysteinylation

Indexed keywords

APOLIPOPROTEIN B; CREATININE; CYSTEINE; CYSTEINYLGLYCINE; GLUTAMYLCYSTEINE; GLUTATHIONE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; LIPID ANALYSIS; MALE; PRIORITY JOURNAL;

AGED; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DYSLIPIDEMIAS; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY DISEASES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEINURIA; RISK FACTORS;

EID: 77955521440     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319012     Document Type: Article

References (38)

1. Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR: Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 2000; 102: 1227-1232.
2. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, De Franceschi M, Belardinelli R, Guazzi MD: Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47: 887-892.
3. Knekt P, Reunanen A, Alfthan G, Heliovaara M, Rissanen H, Marniemi J, Aromaa A: Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease? Arch Intern Med 2001; 161: 1589-1594.
4. Yoo JH, Lee SC: Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 2001; 158: 425-430.
5. Kang SS, Wong PW, Malinow MR: Hyperhomocyst( e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992; 12: 279-298.
6. Den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762.
7. Sjöberg B, Anderstam B, Suliman M, Alvestrand A: Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD. Am J Kidney Dis 2006; 47: 60-71.
8. Brattström L, Wilcken DE: Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000; 72: 315-323.
9. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-614.
10. Perna AF, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, Violetti E, Romano MM, De Santo NG: Possible mechanisms of homocysteine toxicity. Kidney Int 2003; 84:S137-S140.
11. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M, Galletti P, Zappia V: Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uremia. Lancet 2003; 361: 1693-1699.
12. Per?a-Kaján J, Twardowski T, Jakubowski H: Mechanisms of homocysteine toxicity in humans. Amino Acids 2007; 32: 561-572.
13. Yi F, Li PL: Mechanisms of homocysteineinduced glomerular injury and sclerosis. Am J Nephrol 2008; 28: 254-264.
14. Jakubowski H: Homocysteine is a protein amino acid in humans: implications for homocysteine-linked disease. J Biol Chem 2002; 277: 30425-30428.
15. Sengupta S, Chen H, Togawa T, DiBello PM, Majors AK, Büdy B, Ketterer ME, Jacobsen DW: Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine. J Biol Chem 2001; 276: 30111-30117.
16. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT: Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem 1998; 273: 9987-9993.
17. Undas A, Williams EB, Butenas S, Orfeo T, Mann KG: Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem 2001; 276: 4389-4397.
18. Majors AK, Sengupta S, Willard B, Kinter MT, Pyeritz RE, Jacobsen DW: Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol 2002; 22: 1354-1359.
19. Hultberg B, Andersson A, Isaksson A: Protein binding of homocysteine and other thiols in HeLa cell cultures after addition of homocysteine and copper ions. Clin Chim Acta 1998; 269: 175-184.
20. Yang C, Gu ZW, Yang M, Gotto AM Jr: Primary structure of apoB-100. Chem Phys Lipids 1994; 67-68: 99-104.
21. Zinellu A, Sotgia S, Zinellu E, Formato M, Manca S, Magliona S, Ginanneschi R, Deiana L, Carru C: Distribution of low-density lipoprotein-bound low-molecular-weight thiols: a new analytical approach. Electrophoresis 2006; 27: 2575-2581.
22. Zinellu A, Lepedda A Jr, Sotgia S, Zinellu E, Scanu B, Turrini F, Spirito R, Deiana L, Formato M, Carru C: Factors affecting S-homocysteinylation of LDL apoprotein B. Clin Chem 2006; 52: 2054-2059.
23. Zinellu A, Sotgia S, Scanu B, Pintus G, Posadino AM, Cossu A, Deiana L, Sengupta S, Carru C: S-homocysteinylated LDL apolipoprotein B adversely affects human endothelial cells in vitro. Atherosclerosis 2009; 206: 40-46.
24. Vaziri ND: Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 2006; 290:F262-F272.
25. Vaziri ND: Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int 2003; 63: 1964-1976.
26. Himber J, Buhler E, Moll D, Moser UK: Low density lipoprotein for oxidation and metabolic studies. Isolation from small volumes of plasma using a tabletop ultracentrifuge. Int J Vitam Nutr Res 1995; 65: 137-142.
27. McDowell IF, McEneny J, Trimble ER: A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 1995; 32: 167-174.
28. Zinellu A, Carru C, Galistu F, Usai MF, Pes GM, Baggio G, Federici G, Deiana L: Nmethyl- D -glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement. Electrophoresis 2003; 24: 2796-2804.
29. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
30. Zinellu A, Sotgia S, Deiana L, Carru C: Quantification of thiol-containing amino acids linked by disulfides to LDL. Clin Chem 2005; 51: 658-660.
31. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE: European Concerted Action Project. Plasma total cysteine as a risk factor for vascular disease. Circulation 2001; 103: 2544-2549.
32. Bescond A, Augier T, Chareyre C, Garçon D, Hornebeck W, Charpiot P: Influence of homocysteine on matrix metalloproteinase-2: activation and activity. Biochem Biophys Res Commun 1999; 263: 498-503.
33. Hogg N: The effect of cyst(e)ine on the autooxidation of homocysteine. Free Radic Biol Med 1999; 27: 28-33.
34. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
35. Matsuyama Y, Terawaki H, Terada T, Era S: Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Clin Exp Nephrol 2009; 13: 308-315.
36. Hortin GL, Seam N, Hoehn GT: Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin Chem 2006; 52: 2258-2264.
37. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K: Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng 1999; 12: 439-446.
38. Bratzler RL, Chisolm GM, Colton CK, Smith KA, Lees RS: The distribution of labelled low-density lipoprotein across the rabbit thoracic aorta in vivo. Atherosclerosis 1977; 28: 289-307.